In Vivo Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review

被引:42
作者
Ombredane, Alicia S. [1 ,2 ]
Silva, Vitoria R. P. [1 ]
Andrade, Laise R. [3 ]
Pinheiro, Willie O. [4 ]
Simonelly, Mayara [3 ]
Oliveira, Jaqueline, V [5 ]
Pinheiro, Andreia C. [1 ,2 ]
Goncalves, Gabriel F. [1 ]
Felice, Gisela J. [1 ]
Garcia, Monica P. [2 ,3 ]
Campos, Patricia M. [6 ]
Luz, Glecia V. S. [7 ,8 ]
Joanitti, Graziella A. [1 ,2 ,3 ]
机构
[1] Univ Brasilia, Lab Bioact Cpds & Nanobiotechnol LBCNano, Brasilia, DF, Brazil
[2] Univ Brasilia, Inst Biol Sci, Postgrad Program Nanosci & Nanobiotechnol, Brasilia, DF, Brazil
[3] Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, Brasilia, DF, Brazil
[4] Univ Brasilia, Fac Ceilandia, Postgrad Program Sci & Technol Hlth, Brasilia, DF, Brazil
[5] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil
[6] Univ Estadual Ponta Grossa, Pharmaceut Sci Dept, Ponta Grossa, Parana, Brazil
[7] Univ Brasilia, Postgrad Program Biomed Engn PPGEB, Fac Gama FGA, Brasilia, DF, Brazil
[8] Univ Brasilia, Hlth Technol Assessment Ctr NATS UnB, Brasilia, DF, Brazil
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
breast cancer; nanoparticle; curcumin; apoptosis; antitumor; toxicity; in vivo; systematic review; BIODISTRIBUTION; DELIVERY;
D O I
10.3389/fonc.2021.612903
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is one of the most prevalent types of malignant tumors in the world, resulting in a high incidence of death. The development of new molecules and technologies aiming to apply more effective and safer therapy strategies has been intensively explored to overcome this situation. The association of nanoparticles with known antitumor compounds (including plant-derived molecules such as curcumin) has been considered an effective approach to enhance tumor growth suppression and reduce adverse effects. Therefore, the objective of this systematic review was to summarize published data regarding evaluations about efficacy and toxicity of curcumin nanoparticles (Cur-NPs) in in vivo models of breast cancer. The search was carried out in the databases: CINAHL, Cochrane, LILACS, Embase, FSTA, MEDLINE, ProQuest, BSV regional portal, PubMed, ScienceDirect, Scopus, and Web of Science. Studies that evaluated tumor growth in in vivo models of breast cancer and showed outcomes related to Cur-NP treatment (without association with other antitumor molecules) were included. Of the 528 initially gathered studies, 26 met the inclusion criteria. These studies showed that a wide variety of NP platforms have been used to deliver curcumin (e.g., micelles, polymeric, lipid-based, metallic). Attachment of poly(ethylene glycol) chains (PEG) and active targeting moieties were also evaluated. Cur-NPs significantly reduced tumor volume/weight, inhibited cancer cell proliferation, and increased tumor apoptosis and necrosis. Decreases in cancer stem cell population and angiogenesis were also reported. All the studies that evaluated toxicity considered Cur-NP treatment to be safe regarding hematological/biochemical markers, damage to major organs, and/or weight loss. These effects were observed in different in vivo models of breast cancer (e.g., estrogen receptor-positive, triple-negative, chemically induced) showing better outcomes when compared to treatments with free curcumin or negative controls. This systematic review supports the proposal that Cur-NP is an effective and safe therapeutic approach in in vivo models of breast cancer, reinforcing the currently available evidence that it should be further analyzed in clinical trials for breast cancer treatments.
引用
收藏
页数:18
相关论文
共 85 条
[31]   Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles [J].
Jung, Kyung-Ho ;
Lee, Jin Hee ;
Park, Jin Won ;
Kim, Da Hae ;
Moon, Seung-Hwan ;
Cho, Young Seok ;
Lee, Kyung-Han .
ONCOLOGY LETTERS, 2018, 15 (06) :9093-9100
[32]   Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer [J].
Kalyane, Dnyaneshwar ;
Raval, Nidhi ;
Maheshwari, Rahul ;
Tambe, Vishakha ;
Kalia, Kiran ;
Tekade, Rakesh K. .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2019, 98 :1252-1276
[33]   Induction of apoptosis by curcumin and its implications for cancer therapy [J].
Karunagaran, D ;
Rashmi, R ;
Kumar, TRS .
CURRENT CANCER DRUG TARGETS, 2005, 5 (02) :117-129
[34]   Natural product-based nanoformulations for cancer therapy: Opportunities and challenges [J].
Kashyap, Dharambir ;
Tuli, Hardeep Singh ;
Yerer, Mukerrem Betul ;
Sharma, Ajay ;
Sak, Katrin ;
Srivastava, Saumya ;
Pandey, Anjana ;
Garg, Vivek Kumar ;
Sethi, Gautam ;
Bishayee, Anupam .
SEMINARS IN CANCER BIOLOGY, 2021, 69 :5-23
[35]   In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT [J].
Kollenda, Sebastian A. ;
Klose, Jasmin ;
Knuschke, Torben ;
Sokolova, Viktoriya ;
Schmitz, Jochen ;
Staniszewska, Magdalena ;
Costa, Pedro Fragoso ;
Herrmann, Ken ;
Westendorf, Astrid M. ;
Fendler, Wolfgang P. ;
Epple, Matthias .
ACTA BIOMATERIALIA, 2020, 109 :244-253
[36]   pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy [J].
Kundu, Mousumi ;
Sadhukhan, Pritam ;
Ghosh, Noyel ;
Chatterjee, Sharmistha ;
Manna, Prasenjit ;
Das, Joydeep ;
Sil, Parames C. .
JOURNAL OF ADVANCED RESEARCH, 2019, 18 :161-172
[37]   POTENTIAL ANTICANCER ACTIVITY OF TURMERIC (CURCUMA-LONGA) [J].
KUTTAN, R ;
BHANUMATHY, P ;
NIRMALA, K ;
GEORGE, MC .
CANCER LETTERS, 1985, 29 (02) :197-202
[38]   Fabrication of curcumin-loaded folic acid-tagged metal organic framework for triple negative breast cancer therapy in in vitro and in vivo systems [J].
Laha, Dipranjan ;
Pal, Kunal ;
Chowdhuri, Angshuman Ray ;
Parida, Pravat Kumar ;
Sahu, Sumanta Kumar ;
Jana, Kuladip ;
Karmakar, Parimal .
NEW JOURNAL OF CHEMISTRY, 2019, 43 (01) :217-229
[39]   MCF-7 Cells-Changing the Course of Breast Cancer Research and Care for 45 Years [J].
Lee, Adrian V. ;
Oesterreich, Steffi ;
Davidson, Nancy E. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07)
[40]   Curcumin Inhibits Hepatocellular Carcinoma via Regulating miR-21/TIMP3 Axis [J].
Li, Jingtao ;
Wei, Hailiang ;
Liu, Yonggang ;
Li, Qian ;
Guo, Hui ;
Guo, Yingjun ;
Chang, Zhanjie .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020